Posts

Showing posts with the label Sleep Apnea Devices Market Revenue

Sleep Apnea Devices Market Is Likely To Up Demand At A USD 6.9 Billion By 2030: Grand View Research Inc.

  San Francisco, 7 Feb 2024:  The Report  Sleep Apnea Devices Market  Size, Share & Trends Analysis Report By Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks), By End Use, By Region, And Segment Forecasts, 2024 - 2030 The global sleep apnea devices market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.2% from 2023 to 2030. The growing prevalence of chronic disorders such as hypertension, diabetes, cardiovascular diseases, and obesity is increasing the incidence rate & burden of Obstructive Sleep Apnea (OSA). According to World Population Review estimates, the prevalence of obesity in the U.S. accounts for 36.2% of the total population. As per studies, the prevalence of OSA increases with increasing age. The growing global geriatric population with increasing life expectancy is anticipated to contribute to the growing...

Sleep Apnea Devices Market Expanding At A CAGR Of 6.8% For The Forecast Period From 2019 To 2025 : Grand View Research Inc.

San Francisco, 1 July 2019:   The Report   Sleep Apnea Devices Market   Size, Share & Trends Analysis Report By Product [Therapeutic (PAP, Oral, Nasal, Chin), Diagnostic (Respiratory Polygraphs, Actigraph, Polysomnography, Pulse Oximeters)], By Region, 2019 – 2025 The global sleep apnea devices market size is estimated to be worth USD 12.61 billion by 2025, expanding at a CAGR of 6.8% from 2019 to 2025, according to a report by Grand View Research, Inc. Increasing number of patients suffering from sleep apnea, growing awareness, and treatment rate of these diseases in North America are some of the factors contributing to the revenue growth. On the basis of product type, the market is categorized into therapeutic and diagnostic devices. Therapeutic device led the market with about 65.06% of revenue share in 2018, due to increased awareness and patient medication adherence in developed markets such as U.S. and Canada and high prevalence of Obstructive Sle...